Related Experiment Video
Updated: Jun 24, 2026
A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Humanin Mitigates Aβ-Induced Retinal Pigment Epithelium Injury via AMPK-Beclin1-Dependent Mitophagy
Ha Young Jang1,2,3, Suyeon Choi4,5, Soo-Jin Kim4,5
1Fight Against Angiogenesis-Related Blindness (FARB) Laboratory, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
Abstract:
Amyloid beta (Aβ), a key component of drusen in age-related macular degeneration (AMD), induces oxidative stress, mitochondrial dysfunction, and degeneration in the retinal pigment epithelium (RPE), contributing to progressive vision loss in the elderly. We investigated the protective role of Humanin (HN), a mitochondria-derived peptide with known neuroprotective effects in Aβ-related neurodegenerative diseases, in retinal pathology induced by subretinal injection of FITC-labeled Aβ. HN enhanced the clearance of Aβ-accumulated mitochondria in the RPE while preserving retinal function and RPE barrier integrity. In ARPE-19 cells, HN activated AMP-activated protein kinase (AMPK), leading to phosphorylation of ULK1 and Beclin1, which promoted the interaction between Beclin1 and Parkin and their translocation to mitochondria. This process facilitated the removal of Aβ-accumulated mitochondria in the RPE. Our results demonstrate that targeting mitophagy in the RPE with HN may offer a promising therapeutic strategy for AMD.
Insights
Humanin (HN) peptide protects against age-related macular degeneration (AMD) by clearing amyloid beta (Aβ)-damaged mitochondria in retinal cells. This promotes retinal function and offers a potential therapeutic strategy for AMD.
Area of Science:
- Ophthalmology
- Neuroscience
- Cell Biology
Background:
- Amyloid beta (Aβ) accumulation in drusen contributes to retinal pigment epithelium (RPE) degeneration and vision loss in age-related macular degeneration (AMD).
- Mitochondrial dysfunction and oxidative stress are key pathological mechanisms in AMD progression.
- Humanin (HN), a mitochondria-derived peptide, exhibits neuroprotective properties relevant to Aβ-associated neurodegenerative diseases.
Purpose of the Study:
- To investigate the protective effects of Humanin (HN) against amyloid beta (Aβ)-induced retinal pathology.
- To elucidate the underlying molecular mechanisms of HN's protective action, focusing on mitophagy in the retinal pigment epithelium (RPE).
Main Methods:
- Subretinal injection of FITC-labeled Aβ in a rodent model.
- Assessment of retinal function and RPE barrier integrity.
- In vitro studies using ARPE-19 cells to analyze HN's effect on mitophagy pathways, including AMPK, ULK1, Beclin1, and Parkin.
- Mitochondrial clearance assays.
Main Results:
- Humanin (HN) treatment enhanced the clearance of amyloid beta (Aβ)-laden mitochondria in the RPE.
- HN preserved retinal function and maintained RPE barrier integrity following Aβ insult.
- In ARPE-19 cells, HN activated AMP-activated protein kinase (AMPK), promoting ULK1 and Beclin1 phosphorylation.
- HN facilitated the interaction and mitochondrial translocation of Beclin1 and Parkin, enhancing mitophagy.
Conclusions:
- Humanin (HN) demonstrates significant protective effects against Aβ-induced retinal damage.
- HN-mediated mitophagy activation in the RPE is a key mechanism underlying its therapeutic potential.
- Targeting mitophagy with Humanin (HN) represents a promising therapeutic strategy for age-related macular degeneration (AMD).
